Postnatal inflammation in the pathogenesis of bronchopulmonary dysplasia

Birth Defects Research Part A - Clinical and Molecular Teratology

Volumn 100, Issue 3, 2014, Pages 189-201

  Bhandari, Vineet ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Hyperoxia; Infection; Invasive ventilation; Lung; Newborn

Indexed keywords

APELIN; AZITHROMYCIN; BOMBESIN; CAFFEINE; CITRULLINE; COLCHICINE; CONNECTIVE TISSUE GROWTH FACTOR; CURCUMIN; CXCL1 CHEMOKINE; CXCL2 CHEMOKINE; CYTOKINE INDUCED NEUTROPHIL CHEMOATTRACTANT; ELASTIN; GASTRIN RELEASING PEPTIDE; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MATRIX PROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 2; NIGELLA SATIVA EXTRACT; PENTOXIFYLLINE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; SILDENAFIL; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2;

ARTICLE; BABOON; CYTOKINE RELEASE; DEVELOPMENTAL STAGE; DISEASE PREDISPOSITION; GENETIC PREDISPOSITION; GRAM NEGATIVE SEPSIS; HUMAN; HYPEROXIA; INFLAMMATION; INFLAMMATORY CELL; LAMB; LUNG ALVEOLUS MACROPHAGE; LUNG DEVELOPMENT; LUNG DYSPLASIA; LUNG LAVAGE; MONONUCLEAR CELL; MOUSE MODEL; NEUTROPHIL; NONHUMAN; NONINVASIVE VENTILATION; OVINE MODEL; PATHOGENESIS; PERINATAL PERIOD; PNEUMONIA; POSITIVE END EXPIRATORY PRESSURE; PREMATURITY; PRIORITY JOURNAL; RAT MODEL; SEPSIS; TIDAL VOLUME; VIRUS INFECTION; ANIMAL; DISEASE MODEL; METABOLISM; MOUSE; NEWBORN; PATHOLOGY; PATHOPHYSIOLOGY; RAT; SHEEP;

ANIMALIA; PAPIO; RATTUS;

ANIMALS; BRONCHOPULMONARY DYSPLASIA; DISEASE MODELS, ANIMAL; HUMANS; HYPEROXIA; INFANT, NEWBORN; INFANT, PREMATURE; INFLAMMATION; MICE; PAPIO; RATS; SEPSIS; SHEEP;

EID: 84896495561     PISSN: 15420752     EISSN: 15420760     Source Type: Journal    
DOI: 10.1002/bdra.23220     Document Type: Article

References (160)

1. Aghai ZH, Faqiri S, Saslow JG, et al. 2008. Angiopoietin 2 concentrations in infants developing bronchopulmonary dysplasia: attenuation by dexamethasone. J Perinatol 28:149-155.
2. Aghai ZH, Saslow JG, Mody K, et al. 2013. IFN-gamma and IP-10 in tracheal aspirates from premature infants: relationship with bronchopulmonary dysplasia. Pediatr Pulmonol 48:8-13.
3. Akram Khan M, Kuzma-O'Reilly B, Brodsky NL, et al. 2006. Site-specific characteristics of infants developing bronchopulmonary dysplasia. J Perinatol 26:428-435.
4. Alapati D, Rong M, Chen S, et al. 2011. Connective tissue growth factor antibody therapy attenuates hyperoxia-induced lung injury in neonatal rats. Am J Respir Cell Mol Biol 45:1169-1177.
5. Alapati D, Rong M, Chen S, et al. 2013. Inhibition of LRP5/6-mediated Wnt/beta-catenin signaling by Mesd attenuates hyperoxia-induced pulmonary hypertension in neonatal rats. Pediatr Res 73:719-725.
6. Albertine KH, Jones GP, Starcher BC, et al. 1999. Chronic lung injury in preterm lambs. Disordered respiratory tract development. Am J Respir Crit Care Med 159:945-958.
7. Alejandre-Alcazar MA, Kwapiszewska G, Reiss I, et al. 2007. Hyperoxia modulates TGF-beta/BMP signaling in a mouse model of bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol 292:L537-L549.
8. Almario B, Wu S, Peng J, et al. 2012. Pentoxifylline and prevention of hyperoxia-induced lung -injury in neonatal rats. Pediatr Res 71:583-589.
9. Alphonse RS, Vadivel A, Coltan L, et al. 2011. Activation of Akt protects alveoli from neonatal oxygen-induced lung injury. Am J Respir Cell Mol Biol 44:146-154.
10. Alvira CM, Abate A, Yang G, et al. 2007. Nuclear factor-kappaB activation in neonatal mouse lung protects against lipopolysaccharide-induced inflammation. Am J Respir Crit Care Med 175:805-815.
11. Anderson PJ, Doyle LW. 2006. Neurodevelopmental outcome of bronchopulmonary dysplasia. Semin Perinatol 30:227-232.
12. Auten RL Jr, Mason SN, Tanaka DT, et al. 2001. Anti-neutrophil chemokine preserves alveolar development in hyperoxia-exposed newborn rats. Am J Physiol Lung Cell Mol Physiol 281:L336-L344.
13. Auten RL, Mason SN, Whorton MH, et al. 2007. Inhaled ethyl nitrite prevents hyperoxia-impaired postnatal alveolar development in newborn rats. Am J Respir Crit Care Med 176:291-299.
14. Backstrom E, Hogmalm A, Lappalainen U, et al. 2011. Developmental stage is a major determinant of lung injury in a murine model of bronchopulmonary dysplasia. Pediatr Res 69:312-318.
15. Baker CD, Seedorf GJ, Wisniewski BL, et al. 2013. Endothelial colony-forming cell conditioned media promote angiogenesis in vitro and prevent pulmonary hypertension in experimental bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol 305:L73-L81.
16. Ballard HO, Bernard P, Qualls J, et al. 2007. Azithromycin protects against hyperoxic lung injury in neonatal rats. J Investig Med 55:299-305.
17. Bhandari A, Bhandari V. 2003. Pathogenesis, pathology and pathophysiology of pulmonary sequelae of bronchopulmonary dysplasia in premature infants. Front Biosci 8:e370-e380.
18. Bhandari A, Bhandari V. 2009. Pitfalls, problems, and progress in bronchopulmonary dysplasia. Pediatrics 123:1562-1573.
19. Bhandari A, Bhandari V. 2011. "New" bronchopulmonary dysplasia - a clinical review. Clin Pulm Med 18:137-143.
20. Bhandari A, Bhandari V. 2013. Biomarkers in bronchopulmonary dysplasia. Paediatr Respir Rev 14:173-179.
21. Bhandari A, Panitch HB. 2006. Pulmonary outcomes in bronchopulmonary dysplasia. Semin Perinatol 30:219-226.
22. Bhandari V. 2002. Developmental differences in the role of interleukins in hyperoxic lung injury in animal models. Front Biosci 7:d1624-d1633.
23. Bhandari V. 2010. Hyperoxia-derived lung damage in preterm infants. Semin Fetal Neonatal Med 15:223-229.
24. Bhandari V, Choo-Wing R, Lee CG, et al. 2008. Developmental regulation of NO-mediated VEGF-induced effects in the lung. Am J Respir Cell Mol Biol 39:420-430.
25. Bhandari V, Choo-Wing R, Lee CG, et al. 2006. Hyperoxia causes angiopoietin 2-mediated acute lung injury and necrotic cell death. Nat Med 12:1286-1293.
26. Bhandari V, Elias JA. 2006. Cytokines in tolerance to hyperoxia-induced injury in the developing and adult lung. Free Radic Biol Med 41:4-18.
27. Bhatt AJ, Pryhuber GS, Huyck H, et al. 2001. Disrupted pulmonary vasculature and decreased vascular endothelial growth factor, Flt-1, and TIE-2 in human infants dying with bronchopulmonary dysplasia. Am J Respir Crit Care Med 164:1971-1980.
28. Bhattacharya S, Go D, Krenitsky DL, et al. 2012. Genome-wide transcriptional profiling reveals connective tissue mast cell accumulation in bronchopulmonary dysplasia. Am J Respir Crit Care Med 186:349-358.
29. Bland RD, Ertsey R, Mokres LM, et al. 2008. Mechanical ventilation uncouples synthesis and assembly of elastin and increases apoptosis in lungs of newborn mice. Prelude to defective alveolar septation during lung development? Am J Physiol Lung Cell Mol Physiol 294:L3-L14.
30. Bland RD, Xu L, Ertsey R, et al. 2007. Dysregulation of pulmonary elastin synthesis and assembly in preterm lambs with chronic lung disease. Am J Physiol Lung Cell Mol Physiol 292:L1370-L1384.
31. Bozyk PD, Bentley JK, Popova AP, et al. 2012. Neonatal periostin knockout mice are protected from hyperoxia-induced alveolar simplication. PLoS One 7:e31336.
32. Britt RD Jr, Velten M, Tipple TE, et al. 2013. Cyclooxygenase-2 in newborn hyperoxic lung injury. Free Radic Biol Med 61C:502-511.
33. Bry K, Whitsett JA, Lappalainen U. 2007. IL-1beta disrupts postnatal lung morphogenesis in the mouse. Am J Respir Cell Mol Biol 36:32-42.
34. Buczynski BW, Yee M, Paige Lawrence B, et al. 2012. Lung development and the host response to influenza A virus are altered by different doses of neonatal oxygen in mice. Am J Physiol Lung Cell Mol Physiol 302:L1078-L1087.
35. Cannizzaro V, Zosky GR, Hantos Z, et al. 2008. High tidal volume ventilation in infant mice. Respir Physiol Neurobiol 162:93-99.
36. Cetinkaya M, Cansev M, Kafa IM, et al. 2013. Cytidine 5'-diphosphocholine ameliorates hyperoxic lung injury in a neonatal rat model. Pediatr Res 74:26-33.
37. Chen S, Rong M, Platteau A, et al. 2011. CTGF disrupts alveolarization and induces pulmonary hypertension in neonatal mice: implication in the pathogenesis of severe bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol 300:L330-L340.
38. Chetty A, Cao GJ, Severgnini M, et al. 2008. Role of matrix metalloprotease-9 in hyperoxic injury in developing lung. Am J Physiol Lung Cell Mol Physiol 295:L584-L592.
39. Choi CW, Kim BI, Hong JS, et al. 2009. Bronchopulmonary dysplasia in a rat model induced by intra-amniotic inflammation and postnatal hyperoxia: morphometric aspects. Pediatr Res 65:323-327.
40. Choo-Wing R, Nedrelow JH, Homer RJ, et al. 2007. Developmental differences in the responses of IL-6 and IL-13 transgenic mice exposed to hyperoxia. Am J Physiol Lung Cell Mol Physiol 293:L142-L150.
41. Choo-Wing R, Syed MA, Harijith A, et al. 2013. Hyperoxia and interferon-gamma-induced injury in developing lungs occur via cyclooxygenase-2 and the endoplasmic reticulum stress-dependent pathway. Am J Respir Cell Mol Biol 48:749-757.
42. Coalson JJ, Winter VT, Siler-Khodr T, et al. 1999. Neonatal chronic lung disease in extremely immature baboons. Am J Respir Crit Care Med 160:1333-1346.
43. Cole FS, Alleyne C, Barks JD, et al. 2011. NIH Consensus Development Conference statement: inhaled nitric-oxide therapy for premature infants. Pediatrics 127:363-369.
44. Copland IB, Martinez F, Kavanagh BP, et al. 2004. High tidal volume ventilation causes different inflammatory responses in newborn versus adult lung. Am J Respir Crit Care Med 169:739-748.
45. Cotton RB, Sundell HW, Zeldin DC, et al. 2006. Inhaled nitric oxide attenuates hyperoxic lung injury in lambs. Pediatr Res 59:142-146.
46. Couroucli XI, Liang YH, Jiang W, et al. 2011. Prenatal administration of the cytochrome P4501A inducer, Beta-naphthoflavone (BNF), attenuates hyperoxic lung injury in newborn mice: implications for bronchopulmonary dysplasia (BPD) in premature infants. Toxicol Appl Pharmacol 256:83-94.
47. Dang H, Yang L, Wang S, et al. 2012. Calcitonin gene-related peptide ameliorates hyperoxia-induced lung injury in neonatal rats. Tohoku J Exp Med 227:129-138.
48. Dasgupta C, Sakurai R, Wang Y, et al. 2009. Hyperoxia-induced neonatal rat lung injury involves activation of TGF-{beta} and Wnt signaling and is protected by rosiglitazone. Am J Physiol Lung Cell Mol Physiol 296:L1031-L1041.
49. De Paepe ME, Patel C, Tsai A, et al. 2008. Endoglin (CD105) up-regulation in pulmonary microvasculature of ventilated preterm infants. Am J Respir Crit Care Med 178:180-187.
50. de Visser YP, Walther FJ, Laghmani EH, et al. 2008. Phosphodiesterase-4 inhibition attenuates pulmonary inflammation in neonatal lung injury. Eur Respir J 31:633-644.
51. de Visser YP, Walther FJ, Laghmani el H, et al. 2012. Phosphodiesterase 4 inhibition attenuates persistent heart and lung injury by neonatal hyperoxia in rats. Am J Physiol Lung Cell Mol Physiol 302:L56-L67.
52. Franco-Montoya ML, Bourbon JR, Durrmeyer X, et al. 2009. Pulmonary effects of keratinocyte growth factor in newborn rats exposed to hyperoxia. Am J Physiol Lung Cell Mol Physiol 297:L965-L976.
53. Franco ML, Waszak P, Banalec G, et al. 2002. LPS-induced lung injury in neonatal rats: changes in gelatinase activities and consequences on lung growth. Am J Physiol Lung Cell Mol Physiol 282:L491-L500.
54. Frank L. 2003. Protective effect of keratinocyte growth factor against lung abnormalities associated with hyperoxia in prematurely born rats. Biol Neonate 83:263-272.
55. Funk AJ, Mandrell TD, Lokey SJ, et al. 2007. Effects of leukotriene inhibition on pulmonary morphology in rat pup lungs exposed to hyperoxia. Comp Med 57:186-192.
56. Ganter MT, Pittet JF. 2006. Bombesin-like peptides: modulators of inflammation in acute lung injury? Am J Respir Crit Care Med 173:1-2.
57. Gauldie J, Galt T, Bonniaud P, et al. 2003. Transfer of the active form of transforming growth factor-beta 1 gene to newborn rat lung induces changes consistent with bronchopulmonary dysplasia. Am J Pathol 163:2575-2584.
58. Gien J, Kinsella JP. 2011. Pathogenesis and treatment of bronchopulmonary dysplasia. Curr Opin Pediatr 23:305-313.
59. Gortner L, Monz D, Mildau C, et al. 2013. Bronchopulmonary dysplasia in a double-hit mouse model induced by intrauterine hypoxia and postnatal hyperoxia: closer to clinical features? Ann Anat 195:351-358.
60. Harijith A, Choo-Wing R, Cataltepe S, et al. 2011. A role for matrix metalloproteinase 9 in IFNgamma-mediated injury in developing lungs: relevance to bronchopulmonary dysplasia. Am J Respir Cell Mol Biol 44:621-630.
61. Harijith A, Pendyala S, Reddy NM, et al. 2013. Sphingosine kinase 1 deficiency confers protection against hyperoxia-induced bronchopulmonary dysplasia in a murine model: role of S1P signaling and Nox proteins. Am J Pathol 183:1169-1182.
62. Hazinski TA, France M, Kennedy KA, et al. 1989. Cimetidine reduces hyperoxic lung injury in lambs. J Appl Physiol (1985) 67:2586-2592.
63. Hilgendorff A, Parai K, Ertsey R, et al. 2011. Inhibiting lung elastase activity enables lung growth in mechanically ventilated newborn mice. Am J Respir Crit Care Med 184:537-546.
64. Hilgendorff A, Parai K, Ertsey R, et al. 2012. Neonatal mice genetically modified to express the elastase inhibitor elafin are protected against the adverse effects of mechanical ventilation on lung growth. Am J Physiol Lung Cell Mol Physiol 303:L215-L227.
65. Hillman NH, Polglase GR, Pillow JJ, et al. 2011. Inflammation and lung maturation from stretch injury in preterm fetal sheep. Am J Physiol Lung Cell Mol Physiol 300:L232-L241.
66. Hirakawa H, Pierce RA, Bingol-Karakoc G, et al. 2007. Cathepsin S deficiency confers protection from neonatal hyperoxia-induced lung injury. Am J Respir Crit Care Med 176:778-785.
67. Hislop AA. 2002. Airway and blood vessel interaction during lung development. J Anat 201:325-334.
68. Hogmalm A, Sheppard D, Lappalainen U, et al. 2010. beta6 Integrin subunit deficiency alleviates lung injury in a mouse model of bronchopulmonary dysplasia. Am J Respir Cell Mol Biol 43:88-98.
69. Hummler SC, Rong M, Chen S, et al. 2013. Targeting glycogen synthase kinase-3beta to prevent hyperoxia-induced lung injury in neonatal rats. Am J Respir Cell Mol Biol 48:578-588.
70. Ikegami M, Moss TJ, Kallapur SG, et al. 2003. Minimal lung and systemic responses to TNF-alpha in preterm sheep. Am J Physiol Lung Cell Mol Physiol 285:L121-L129.
71. Iosef C, Alastalo TP, Hou Y, et al. 2012. Inhibiting NF-kappaB in the developing lung disrupts angiogenesis and alveolarization. Am J Physiol Lung Cell Mol Physiol 302:L1023-L1036.
72. James ML, Ross AC, Nicola T, et al. 2013. VARA attenuates hyperoxia-induced impaired alveolar development and lung function in newborn mice. Am J Physiol Lung Cell Mol Physiol 304:L803-L812.
73. Joshi S, Kotecha S. 2007. Lung growth and development. Early Hum Dev 83:789-794.
74. Kevill KA, Bhandari V, Kettunen M, et al. 2008. A role for macrophage migration inhibitory factor in the neonatal respiratory distress syndrome. J Immunol 180:601-608.
75. Kim DH, Choi CW, Kim EK, et al. 2010. Association of increased pulmonary interleukin-6 with the priming effect of intra-amniotic lipopolysaccharide on hyperoxic lung injury in a rat model of bronchopulmonary dysplasia. Neonatology 98:23-32.
76. Kompass KS, Deslee G, Moore C, et al. 2010. Highly conserved transcriptional responses to mechanical ventilation of the lung. Physiol Genomics 42:384-396.
77. Kornecki A, Tsuchida S, Ondiveeran HK, et al. 2005. Lung development and susceptibility to ventilator-induced lung injury. Am J Respir Crit Care Med 171:743-752.
78. Kotecha S. 2000. Lung growth: implications for the newborn infant. Arch Dis Child Fetal Neonatal Ed 82:F69-F74.
79. Kramer EL, Deutsch GH, Sartor MA, et al. 2007. Perinatal increases in TGF-{alpha} disrupt the saccular phase of lung morphogenesis and cause remodeling: microarray analysis. Am J Physiol Lung Cell Mol Physiol 293:L314-L327.
80. Kroon AA, Wang J, Huang Z, et al. 2010. Inflammatory response to oxygen and endotoxin in newborn rat lung ventilated with low tidal volume. Pediatr Res 68:63-69.
81. Kroon AA, Wang J, Kavanagh BP, et al. 2011. Prolonged mechanical ventilation induces cell cycle arrest in newborn rat lung. PLoS One 6:e16910.
82. Kunig AM, Balasubramaniam V, Markham NE, et al. 2005. Recombinant human VEGF treatment enhances alveolarization after hyperoxic lung injury in neonatal rats. Am J Physiol Lung Cell Mol Physiol 289:L529-L535.
83. Kunig AM, Balasubramaniam V, Markham NE, et al. 2006. Recombinant human VEGF treatment transiently increases lung edema but enhances lung structure after neonatal hyperoxia. Am J Physiol Lung Cell Mol Physiol 291:L1068-L1078.
84. Ladha F, Bonnet S, Eaton F, et al. 2005. Sildenafil improves alveolar growth and pulmonary hypertension in hyperoxia-induced lung injury. Am J Respir Crit Care Med 172:750-756.
85. Lassus P, Turanlahti M, Heikkila P, et al. 2001. Pulmonary vascular endothelial growth factor and Flt-1 in fetuses, in acute and chronic lung disease, and in persistent pulmonary hypertension of the newborn. Am J Respir Crit Care Med 164:1981-1987.
86. Lee HJ, Choi CW, Kim BI, et al. 2010. Serial changes of lung morphology and biochemical profiles in a rat model of bronchopulmonary dysplasia induced by intra-amniotic lipopolysaccharide and postnatal hyperoxia. J Perinat Med 38:675-681.
87. Lee PT, Holt PG, McWilliam AS. 2000. Role of alveolar macrophages in innate immunity in neonates: evidence for selective lipopolysaccharide binding protein production by rat neonatal alveolar macrophages. Am J Respir Cell Mol Biol 23:652-661.
88. Lee PT, Holt PG, McWilliam AS. 2001. Ontogeny of rat pulmonary alveolar macrophage function: evidence for a selective deficiency in il-10 and nitric oxide production by newborn alveolar macrophages. Cytokine 15:53-57.
89. Li Z, Choo-Wing R, Sun H, et al. 2011. A potential role of the JNK pathway in hyperoxia-induced cell death, myofibroblast transdifferentiation and TGF-beta1-mediated injury in the developing murine lung. BMC Cell Biol 12:54.
90. Lindsay L, Oliver SJ, Freeman SL, et al. 2000. Modulation of hyperoxia-induced TNF-alpha expression in the newborn rat lung by thalidomide and dexamethasone. Inflammation 24:347-356.
91. Londhe VA, Belperio JA, Keane MP, et al. 2005. CXCR2/CXCR2 ligand biological axis impairs alveologenesis during dsRNA-induced lung inflammation in mice. Pediatr Res 58:919-926.
92. Londhe VA, Maisonet TM, Lopez B, et al. 2011. Conditional deletion of epithelial IKKbeta impairs alveolar formation through apoptosis and decreased VEGF expression during early mouse lung morphogenesis. Respir Res 12:134.
93. Londhe VA, Sundar IK, Lopez B, et al. 2011. Hyperoxia impairs alveolar formation and induces senescence through decreased histone deacetylase activity and up-regulation of p21 in neonatal mouse lung. Pediatr Res 69:371-377.
94. Ma L, Li N, Liu X, et al. 2012. Arginyl-glutamine dipeptide or docosahexaenoic acid attenuate hyperoxia-induced lung injury in neonatal mice. Nutrition 28:1186-1191.
95. Maeda Y, Dave V, Whitsett JA. 2007. Transcriptional control of lung morphogenesis. Physiol Rev 87:219-244.
96. Manisalco WM and Bhandari V (2010). Disruption of lung microvascular development. In: Abman SH, editor. Bronchopulmonary dysplasia. New York: Informa Healthcare. pp. 146-166.
97. Maniscalco WM, Watkins RH, Pryhuber GS, et al. 2002. Angiogenic factors and alveolar vasculature: development and alterations by injury in very premature baboons. Am J Physiol Lung Cell Mol Physiol 282:L811-L823.
98. Martin TR, Ruzinski JT, Wilson CB, et al. 1995. Effects of endotoxin in the lungs of neonatal rats: age-dependent impairment of the inflammatory response. J Infect Dis 171:134-144.
99. Mascaretti RS, Mataloun MM, Dolhnikoff M, et al. 2009. Lung morphometry, collagen and elastin content: changes after hyperoxic exposure in preterm rabbits. Clinics (Sao Paulo) 64:1099-1104.
100. McGrath-Morrow S, Lauer T, Yee M, et al. 2009. Nrf2 increases survival and attenuates alveolar growth inhibition in neonatal mice exposed to hyperoxia. Am J Physiol Lung Cell Mol Physiol 296:L565-L573.
101. McGrath-Morrow SA, Cho C, Soutiere S, et al. 2004. The effect of neonatal hyperoxia on the lung of p21Waf1/Cip1/Sdi1-deficient mice. Am J Respir Cell Mol Biol 30:635-640.
102. McGrath-Morrow SA, Stahl J. 2001. Apoptosis in neonatal murine lung exposed to hyperoxia. Am J Respir Cell Mol Biol 25:150-155.
103. Meller S, Bhandari V. 2012. VEGF levels in humans and animal models with RDS and BPD: temporal relationships. Exp Lung Res 38:192-203.
104. Min JH, Codipilly CN, Nasim S, et al. 2012. Synergistic protection against hyperoxia-induced lung injury by neutrophils blockade and EC-SOD overexpression. Respir Res 13:58.
105. Mokres LM, Parai K, Hilgendorff A, et al. 2010. Prolonged mechanical ventilation with air induces apoptosis and causes failure of alveolar septation and angiogenesis in lungs of newborn mice. Am J Physiol Lung Cell Mol Physiol 298:L23-L35.
106. Naik AS, Kallapur SG, Bachurski CJ, et al. 2001. Effects of ventilation with different positive end-expiratory pressures on cytokine expression in the preterm lamb lung. Am J Respir Crit Care Med 164:494-498.
107. Nakanishi H, Sugiura T, Streisand JB, et al. 2007. TGF-beta-neutralizing antibodies improve pulmonary alveologenesis and vasculogenesis in the injured newborn lung. Am J Physiol Lung Cell Mol Physiol 293:L151-L161.
108. O'Reilly MA, Marr SH, Yee M, et al. 2008. Neonatal hyperoxia enhances the inflammatory response in adult mice infected with influenza A virus. Am J Respir Crit Care Med 177:1103-1110.
109. Ohki Y, Mayuzumi H, Tokuyama K, et al. 2009. Hepatocyte growth factor treatment improves alveolarization in a newborn murine model of bronchopulmonary dysplasia. Neonatology 95:332-338.
110. Ozdemir R, Yurttutan S, Talim B, et al. 2012. Colchicine protects against hyperoxic lung injury in neonatal rats. Neonatology 102:265-269.
111. Park HS, Park JW, Kim HJ, et al. 2013. Sildenafil alleviates bronchopulmonary dysplasia in neonatal rats by activating the hypoxia-inducible factor signaling pathway. Am J Respir Cell Mol Biol 48:105-113.
112. Pierro M, Ionescu L, Montemurro T, et al. 2013. Short-term, long-term and paracrine effect of human umbilical cord-derived stem cells in lung injury prevention and repair in experimental bronchopulmonary dysplasia. Thorax 68:475-484.
113. Polglase GR, Hillman NH, Ball MK, et al. 2009. Lung and systemic inflammation in preterm lambs on continuous positive airway pressure or conventional ventilation. Pediatr Res 65:67-71.
114. Rehan VK, Fong J, Lee R, et al. 2011. Mechanism of reduced lung injury by high-frequency nasal ventilation in a preterm lamb model of neonatal chronic lung disease. Pediatr Res 70:462-466.
115. Rehan VK, Torday JS. 2006. Lower parathyroid hormone-related protein content of tracheal aspirates in very low birth weight infants who develop bronchopulmonary dysplasia. Pediatr Res 60:216-220.
116. Reyburn B, Li M, Metcalfe DB, et al. 2008. Nasal ventilation alters mesenchymal cell turnover and improves alveolarization in preterm lambs. Am J Respir Crit Care Med 178:407-418.
117. Sakurai R, Li Y, Torday JS, et al. 2011. Curcumin augments lung maturation, preventing neonatal lung injury by inhibiting TGF-beta signaling. Am J Physiol Lung Cell Mol Physiol 301:L721-L730.
118. Schittny JC and Burri PH (2008). Development and growth of the lung. In: Fishman AP, editor. Fishman's pulmonary diseases and disorders. New York: McGraw-Hill. pp. 91-114.
119. Shashikant BN, Miller TL, Welch RW, et al. 2005. Dose response to rhCC10-augmented surfactant therapy in a lamb model of infant respiratory distress syndrome: physiological, inflammatory, and kinetic profiles. J Appl Physiol (1985) 99:2204-2211.
120. Shivanna B, Zhang W, Jiang W, et al. 2013. Functional deficiency of aryl hydrocarbon receptor augments oxygen toxicity-induced alveolar simplification in newborn mice. Toxicol Appl Pharmacol 267:209-217.
121. Smith VC, Zupancic JA, McCormick MC, et al. 2005. Trends in severe bronchopulmonary dysplasia rates between 1994 and 2002. J Pediatr 146:469-473.
122. Sohn MH, Kang MJ, Matsuura H, et al. 2010. The chitinase-like proteins breast regression protein-39 and YKL-40 regulate hyperoxia-induced acute lung injury. Am J Respir Crit Care Med 182:918-928.
123. Subramaniam M, Bausch C, Twomey A, et al. 2007. Bombesin-like peptides modulate alveolarization and angiogenesis in bronchopulmonary dysplasia. Am J Respir Crit Care Med 176:902-912.
124. Subramaniam M, Sugiyama K, Coy DH, et al. 2003. Bombesin-like peptides and mast cell responses: relevance to bronchopulmonary dysplasia? Am J Respir Crit Care Med 168:601-611.
125. Sun H, Choo-Wing R, Fan J, et al. 2013. Small molecular modulation of macrophage migration inhibitory factor in the hyperoxia-induced mouse model of bronchopulmonary dysplasia. Respir Res 14:27.
126. Sun H, Choo-Wing R, Sureshbabu A, et al. 2013. A critical regulatory role for macrophage migration inhibitory factor in hyperoxia-induced injury in the developing murine lung. PLoS One 8:e60560.
127. Sunday ME, Yoder BA, Cuttitta F, et al. 1998. Bombesin-like peptide mediates lung injury in a baboon model of bronchopulmonary dysplasia. J Clin Invest 102:584-594.
128. Syed MA, Bhandari V. 2013. Hyperoxia exacerbates postnatal inflammation-induced lung injury in neonatal BRP-39 mull mutant mice promoting the M1 macrophage phenotype. Mediators Inflamm 2013:457189.
129. Takeda K, Okamoto M, de Langhe S, et al. 2009. Peroxisome proliferator-activated receptor-g agonist treatment increases septation and angiogenesis and decreases airway hyperresponsiveness in a model of experimental neonatal chronic lung disease. Anat Rec (Hoboken) 292:1045-1061.
130. Tambunting F, Beharry KD, Hartleroad J, et al. 2005. Increased lung matrix metalloproteinase-9 levels in extremely premature baboons with bronchopulmonary dysplasia. Pediatr Pulmonol 39:5-14.
131. Tambunting F, Beharry KD, Waltzman J, et al. 2005. Impaired lung vascular endothelial growth factor in extremely premature baboons developing bronchopulmonary dysplasia/chronic lung disease. J Investig Med 53:253-262.
132. Tayman C, Cekmez F, Kafa IM, et al. 2013. Protective effects of Nigella sativa oil in hyperoxia-induced lung injury. Arch Bronconeumol 49:15-21.
133. ter Horst SA, Walther FJ, Poorthuis BJ, et al. 2007. Inhaled nitric oxide attenuates pulmonary inflammation and fibrin deposition and prolongs survival in neonatal hyperoxic lung injury. Am J Physiol Lung Cell Mol Physiol 293:L35-L44.
134. Thebaud B, Ladha F, Michelakis ED, et al. 2005. Vascular endothelial growth factor gene therapy increases survival, promotes lung angiogenesis, and prevents alveolar damage in hyperoxia-induced lung injury: evidence that angiogenesis participates in alveolarization. Circulation 112:2477-2486.
135. Thomas W, Speer CP. 2013. Chorioamnionitis is essential in the evolution of bronchopulmonary dysplasia - the case in favour. Paediatr Respir Rev [Epub ahead of print].
136. Thomson MA, Yoder BA, Winter VT, et al. 2006. Delayed extubation to nasal continuous positive airway pressure in the immature baboon model of bronchopulmonary dysplasia: lung clinical and pathological findings. Pediatrics 118:2038-2050.
137. Thomson MA, Yoder BA, Winter VT, et al. 2004. Treatment of immature baboons for 28 days with early nasal continuous positive airway pressure. Am J Respir Crit Care Med 169:1054-1062.
138. Thurlbeck WM. 1975. Lung growth and alveolar multiplication. Pathobiol Annu 5:1-34.
139. Tibboel J, Joza S, Reiss I, et al. 2013. Amelioration of hyperoxia-induced lung injury using a sphingolipid-based intervention. Eur Respir J 42:776-784.
140. Tillema MS, Lorenz KL, Weiss MG, et al. 2000. Sublethal endotoxemia promotes pulmonary cytokine-induced neutrophil chemoattractant expression and neutrophil recruitment but not overt lung injury in neonatal rats. Biol Neonate 78:308-314.
141. Trembath A, Laughon MM. 2012. Predictors of bronchopulmonary dysplasia. Clin Perinatol 39:585-601.
142. Trummer-Menzi E, Gremlich S, Schittny JC, et al. 2012. Evolution of gene expression changes in newborn rats after mechanical ventilation with reversible intubation. Pediatr Pulmonol 47:1204-1214.
143. Vadivel A, Aschner JL, Rey-Parra GJ, et al. 2010. L-citrulline attenuates arrested alveolar growth and pulmonary hypertension in oxygen-induced lung injury in newborn rats. Pediatr Res 68:519-525.
144. van Haaften T, Byrne R, Bonnet S, et al. 2009. Airway delivery of mesenchymal stem cells prevents arrested alveolar growth in neonatal lung injury in rats. Am J Respir Crit Care Med 180:1131-1142.
145. Velten M, Heyob KM, Rogers LK, et al. 2010. Deficits in lung alveolarization and function after systemic maternal inflammation and neonatal hyperoxia exposure. J Appl Physiol (1985) 108:1347-1356.
146. Vicencio AG, Lee CG, Cho SJ, et al. 2004. Conditional overexpression of bioactive transforming growth factor-beta1 in neonatal mouse lung: a new model for bronchopulmonary dysplasia? Am J Respir Cell Mol Biol 31:650-656.
147. Viscardi RM. 2012. Perinatal inflammation and lung injury. Semin Fetal Neonatal Med 17:30-35.
148. Visser YP, Walther FJ, Laghmani el H, et al. 2010. Apelin attenuates hyperoxic lung and heart injury in neonatal rats. Am J Respir Crit Care Med 182:1239-1250.
149. Vosdoganes P, Lim R, Koulaeva E, et al. 2013. Human amnion epithelial cells modulate hyperoxia-induced neonatal lung injury in mice. Cytotherapy 15:1021-1029.
150. Warner BB, Stuart LA, Papes RA, et al. 1998. Functional and pathological effects of prolonged hyperoxia in neonatal mice. Am J Physiol 275:L110-L117.
151. Weichelt U, Cay R, Schmitz T, et al. 2013. Prevention of hyperoxia-mediated pulmonary inflammation in neonatal rats by caffeine. Eur Respir J 41:966-973.
152. Wilson TC, Bachurski CJ, Ikegami M, et al. 2005. Pulmonary and systemic induction of SAA3 after ventilation and endotoxin in preterm lambs. Pediatr Res 58:1204-1209.
153. Woyda K, Koebrich S, Reiss I, et al. 2009. Inhibition of phosphodiesterase 4 enhances lung alveolarisation in neonatal mice exposed to hyperoxia. Eur Respir J 33:861-870.
154. Wu S, Capasso L, Lessa A, et al. 2008. High tidal volume ventilation activates Smad2 and upregulates expression of connective tissue growth factor in newborn rat lung. Pediatr Res 63:245-250.
155. Wu S, Platteau A, Chen S, et al. 2010. Conditional overexpression of connective tissue growth factor disrupts postnatal lung development. Am J Respir Cell Mol Biol 42:552-563.
156. Yee M, Chess PR, McGrath-Morrow SA, et al. 2009. Neonatal oxygen adversely affects lung function in adult mice without altering surfactant composition or activity. Am J Physiol Lung Cell Mol Physiol 297:L641-L649.
157. Yoo HS, Chang YS, Kim JK, et al. 2013. Antenatal betamethasone attenuates intrauterine infection-aggravated hyperoxia-induced lung injury in neonatal rats. Pediatr Res 73:726-733.
158. Zhang H, Fang J, Su H, et al. 2012. Bone marrow mesenchymal stem cells attenuate lung inflammation of hyperoxic newborn rats. Pediatr Transplant 16:589-598.
159. Zhang X, Peng W, Zhang S, et al. 2011. MicroRNA expression profile in hyperoxia-exposed newborn mice during the development of bronchopulmonary dysplasia. Respir Care 56:1009-1015.
160. Zhang X, Wang H, Shi Y, et al. 2012. Role of bone marrow-derived mesenchymal stem cells in the prevention of hyperoxia-induced lung injury in newborn mice. Cell Biol Int 36:589-594.